NEWS  /  Brief News

Dye & Durham Lenders Tap Advisers as Debt Pressure Persists

Jul 27, 2026, 4:32 p.m. ET

Lenders to Dye & Durham have tapped advisers as the Canadian legal-software company continues to trade under a heavy debt burden. The company reported C$91.2 million of revenue and C$42.9 million of adjusted EBITDA in the quarter ended March 31, 2026, but still carried more than C$1.2 billion of loans and borrowings and C$338.3 million of convertible debentures at March 31.

NextFin News - Lenders to Dye & Durham are turning to advisers at a moment when the Canadian legal-software group is still trying to prove that its operating recovery can outrun its debt burden. The company posted C$91.2 million in revenue and C$42.9 million in adjusted EBITDA for the quarter ended March 31, 2026, and it said it had reduced debt. Yet its latest public filings still show C$1.267 billion of non-current loans and borrowings, C$338.3 million of convertible debentures and a first-lien leverage ratio of about 5.52x as of March 31. On July 23, the stock closed at C$1.19 on the Toronto Stock Exchange, leaving equity priced far below the company’s 52-week high of C$12.13 and close to the bottom of its trading range.

The tension in the story is simple: the business is generating cash, but not enough to make the capital structure feel routine. Dye & Durham’s own results show why lenders would be inclined to prepare for a wider set of outcomes. Revenue in the fiscal third quarter fell to C$91.2 million from C$103.4 million a year earlier on a restated basis. For the first nine months of fiscal 2026, revenue was C$306.5 million, down from C$335.6 million, while adjusted EBITDA slipped to C$143.7 million from C$185.1 million. The company said the quarter benefited from the Credas disposal and operating improvements, but it also said lower volumes, pricing pressure from customer losses and continued market softness were still weighing on performance.

That matters because the debt stack remains large relative to the business’s current earning power. At March 31, the company reported C$31.5 million drawn on its revolving credit facility, C$26.6 million of current loans and borrowings, C$1.143 billion of non-current loans and borrowings, and C$131.3 million of convertible debentures on the balance sheet. Cash and cash equivalents were C$35.6 million. The company also said it was in compliance with the financial maintenance covenant under its senior credit agreement for the quarter, but compliance is not the same thing as comfort when leverage still sits above 5x.

That is why the lender adviser move should be read as an expectation-gap event rather than a pure operations story. The market already knew Dye & Durham was distressed. What changes when lenders tap advisers is the probability that the next step is not merely a routine amendment, but a more deliberate negotiation over maturities, collateral, covenant relief or an exchange. In other words, the fight is shifting from whether the company can keep running to how much of its future cash flow creditors will need to claim before equity can recover anything meaningful.

Dye & Durham itself has given lenders plenty of reasons to be cautious. In its May results, the company said it no longer expected to achieve high single-digit organic revenue growth within the three-to-five-year period it had previously described. It cited lower-than-expected transaction volumes in core business lines, continued softness in real-estate activity, longer sales cycles and increased competition from new entrants. That is a material change in the operating story. A lender can live with a temporary margin dip. It is far less forgiving when the company says the growth path that would have made leverage manageable is no longer the path it had originally described.

“The Company no longer expects to achieve high single digits Organic Revenue Growth within the three-to-five-year time frame,” Dye & Durham said in its May results update, citing lower transaction volumes, softer real-estate activity, longer sales cycles and new competition.

The stock market has already moved from skepticism to distress pricing. With the shares at C$1.19, the equity is trading near the low end of the 52-week range and roughly 90% below the peak. That price does not require a smooth refinancing to exist; it merely reflects the possibility that lenders will take a larger share of the future than shareholders had hoped. The more important point is that the market is no longer debating whether the business is better or worse than a year ago. It is debating where the value sits in the capital structure.

Why The Lenders’ Adviser Move Matters More Than Another Earnings Beat

The adviser move matters because it changes the information flow. Once creditors hire restructuring or special-situation advisers, the process usually becomes more formal, more segmented and more strategic. Groups line up. Documents get examined with a different lens. A company that was previously negotiating from the perspective of an operating business now negotiates against a backdrop of recovery analysis. That shift can happen before any public sign of default, and it often does.

Dye & Durham’s latest quarter provides the operating context, but not enough relief to neutralize that creditor lens. Revenue fell 12% year over year in the quarter to C$91.2 million, while adjusted EBITDA fell 19% to C$42.9 million. Over nine months, revenue was down 9% and adjusted EBITDA down 22%. Those are not catastrophic declines, but they are enough to slow the pace at which debt can be reduced. The company’s own disclosures also show that finance costs remained material: the quarter included higher finance cost as one of the reasons net income was affected even after the Credas-related gain.

That is the mechanism. Lower organic growth means less room to de-lever. Higher finance costs consume more of the cash that could have gone to debt reduction. The result is a narrower corridor between operating stability and capital-structure stress. If the company were growing faster, lenders might be willing to wait for the balance sheet to self-correct. If the company were generating substantially more cash, the adviser move would matter less. But with the current combination of slower growth, heavy debt and a soft operating backdrop, lender coordination becomes the central issue.

The company has also already signaled that dividends are off the table. In the May release, the board said it has indefinitely suspended the declaration and payment of dividends until further notice, citing debt reduction and capital reinvestment priorities. That is rational treasury management, but it also reinforces the point that equity holders are not being paid to wait. When dividends disappear, the stock is left with only the possibility of future deleveraging or a strategic transaction to justify a recovery.

There is a second-order implication here that is easy to miss. The lender adviser move is not just about Dye & Durham. It is also about how the market prices software and workflow businesses whose recurring revenue no longer translates cleanly into balance-sheet flexibility. In a more forgiving rate environment, a recurring-revenue business could often refinance its way out of trouble. In a tighter one, recurring revenue may only buy time. That is why the story is broader than one issuer: it is a test of how much leverage investors are willing to tolerate in software names where organic growth has slowed.

The company’s recent filings make the pressure visible. At March 31, it reported cash of C$35.6 million against total liabilities of C$1.536 billion and total debt obligations that still included more than C$1.1 billion of non-current loans and borrowings. Even after the debt reduction management described, the leverage profile is still high enough that any disappointment on growth or cash generation can quickly turn into a lender-led process. This is why the market reacts so strongly to adviser hires: it is not the first bad sign, it is the sign that bad signs are now being organized into a legal and financial strategy.

“We are executing against our transformation program, driving cost savings and reinvesting in the core business,” Chief Executive Officer George Tsivin said in the company’s May results release. “We remain focused on operational discipline, product innovation, and customer value.”

That management line is credible as a description of effort, but effort is not the same as resolution. The strongest counter-thesis is that Dye & Durham still has enough recurring software cash flow to refinance, extend and wait out the stress without a more severe restructuring. That argument is not trivial. The company remained in covenant compliance in the quarter, produced positive adjusted EBITDA and showed some net income improvement thanks in part to the Credas sale. Lenders sometimes prefer to negotiate maturity relief if the underlying business appears serviceable and liquidation value is unattractive.

But the counter-thesis has a limit: it depends on the company proving that operating improvement is strong enough to compress leverage faster than the debt clock is running. The falsifying signal for the structural-distress view is measurable. If Dye & Durham can keep revenue roughly stable or growing, continue reducing debt, and avoid a broader exchange, covenant reset or capital-structure overhaul over the next several quarters, then the adviser move will have been a cautionary step rather than the start of a deeper restructuring cycle.

Until then, the burden of proof sits with the company, not the lenders. The operating story may be improving at the margin. The balance-sheet story is still the one that matters most.

What The Market Is Pricing, And What Could Change It

Short term, equity investors are exposed to every delay in the lender process. That is because the stock is already trading like a stressed claim on residual value. If advisers are now involved on the creditor side, the next headlines are more likely to be about extensions, exchanges, collateral discussions or asset-sale timing than about simple growth acceleration. For the shares, that usually means volatility stays high and the upside depends on a cleaner-than-expected liability solution.

Credit holders are in the opposite position. Advisers can help them organize, compare recovery options and protect their position if the company needs more than a small amendment. The company itself may benefit if the process leads to more time and a more orderly debt profile. But each extra round of negotiation also increases the chance that equity is diluted by economics if not by shares.

Medium term, the critical datapoints are revenue stability, adjusted EBITDA conversion, cash generation and debt reduction. The company’s latest results showed C$143.7 million of adjusted EBITDA for the first nine months of fiscal 2026 and C$87.9 million of cash flow from operations over the same period. Those figures are enough to keep the business alive, but not enough to remove leverage as the dominant valuation factor. The company’s debt load still dwarfs its quarterly cash generation, so even modest misses can matter.

Long term, the central question is whether Dye & Durham can rebuild a growth profile that justifies its software valuation before the debt structure forces a different answer. The company has already told investors that the old high-single-digit organic growth path is no longer realistic on the original timeline. That makes the current story less cyclical and more structural: the operating reset and the leverage reset are now happening at the same time. If the business cannot re-accelerate while deleveraging, lenders will continue to set the terms.

The base case is that lenders stay organized, management keeps pushing cost control and debt reduction, and the company seeks to buy time through amendments or other liability management steps. The upside case is a cleaner refinancing path supported by steadier revenue and continued cash generation, which would reduce the odds of a more severe capital-structure event. The downside case is a broader exchange or more formal restructuring if growth stalls, asset-sale timing slips or lender tolerance weakens.

The next thing to watch is not just the company’s next earnings release. It is whether lenders continue to coordinate in public and whether Dye & Durham can show another quarter of debt reduction without sacrificing operating momentum. If those two lines diverge further, the market will keep treating the equity as a claim on a fix that has not arrived yet.

This is not a broken software story. It is a balance-sheet story with software attached.

Please sign in and then enter your comment